Triol form of rosuvastatin and synthesis of rosuvastatin

Details Triol form of rosuvastatin and synthesis of rosuvastatin Triol form of rosuvastatin and synthesis of rosuvastatin

2008-03-13

2010-12-14

Zucker, Paul A (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C436S131000

Reexamination Certificate

active

07851624

ABSTRACT:
Provided is a rosuvastatin triol and its use as a reference standard for analysis of rosuvastatin. Also provided are methods for preparation of rosuvastatin.

REFERENCES:
patent: 4231938 (1980-11-01), Monaghan et al.
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4444784 (1984-04-01), Hoffman et al.
patent: 4645854 (1987-02-01), Verhoeven et al.
patent: 4739073 (1988-04-01), Kathawala
patent: 5003080 (1991-03-01), Butler et al.
patent: 5006530 (1991-04-01), Angerbauer et al.
patent: 5177080 (1993-01-01), Angerbauer et al.
patent: 5189164 (1993-02-01), Kapa et al.
patent: 5202029 (1993-04-01), Haytko et al.
patent: 5218138 (1993-06-01), Chiu et al.
patent: 5260440 (1993-11-01), Hirai et al.
patent: 5354772 (1994-10-01), Kathawala
patent: 5354879 (1994-10-01), Konoike et al.
patent: 5677455 (1997-10-01), Harada et al.
patent: 5717124 (1998-02-01), Harada et al.
patent: 5741934 (1998-04-01), Sandler et al.
patent: 5856336 (1999-01-01), Fujikawa et al.
patent: 6124340 (2000-09-01), Horvath
patent: RE37314 (2001-08-01), Hirai et al.
patent: 6333198 (2001-12-01), Edmeades et al.
patent: 6437065 (2002-08-01), Ritter et al.
patent: 6696479 (2004-02-01), Van Der Schaaf et al.
patent: 6777552 (2004-08-01), Niddam-Hildesheim et al.
patent: 6835838 (2004-12-01), Chen et al.
patent: 6858618 (2005-02-01), Raza et al.
patent: 7208623 (2007-04-01), Sedelmeier et al.
patent: 7232920 (2007-06-01), Puthiaparampil et al.
patent: 7368468 (2008-05-01), Lifshitz-Liron et al.
patent: 7396927 (2008-07-01), Niddam-Hildesheim et al.
patent: 7414140 (2008-08-01), Lifshitz-Liron et al.
patent: 2002/0161021 (2002-10-01), Bosch et al.
patent: 2003/0232989 (2003-12-01), Antons et al.
patent: 2004/0249154 (2004-12-01), Chen et al.
patent: 2005/0032884 (2005-02-01), Lifshitz-Liron et al.
patent: 2005/0038114 (2005-02-01), Lifshitz-Liron et al.
patent: 2005/0080134 (2005-04-01), Niddam-Hildesheim et al.
patent: 2005/0159615 (2005-07-01), Lifshitz-Liron et al.
patent: 2006/0258882 (2006-11-01), Niddam-Hildesheim et al.
patent: 2007/0037979 (2007-02-01), Niddam-Hildesheim et al.
patent: 2007/0179166 (2007-08-01), Niddam-Hildesheim et al.
patent: 2007/0191436 (2007-08-01), Niddam-Hildesheim et al.
patent: 2008/0091014 (2008-04-01), Huang
patent: 1 733 737 (2006-02-01), None
patent: 1807417 (2006-07-01), None
patent: 1821242 (2006-08-01), None
patent: 1 872 841 (2006-12-01), None
patent: 1307187 (2007-03-01), None
patent: 1 958 593 (2007-05-01), None
patent: 1958593 (2007-05-01), None
patent: 298330 (2007-08-01), None
patent: 0 065 835 (1985-11-01), None
patent: 0 363 934 (1990-04-01), None
patent: 0 554 455 (1993-08-01), None
patent: 1 816 126 (2007-08-01), None
patent: 07 118233 (1995-05-01), None
patent: WO 03/004455 (2003-01-01), None
patent: WO 03/087112 (2003-10-01), None
patent: WO 03/097614 (2003-11-01), None
patent: WO 2004/094343 (2004-11-01), None
patent: WO 2004/108691 (2004-12-01), None
patent: WO 2005/023778 (2005-03-01), None
patent: WO 2005/040134 (2005-05-01), None
patent: WO 2005/056534 (2005-06-01), None
patent: WO 2005/077916 (2005-08-01), None
patent: WO 2006/067456 (2006-06-01), None
patent: WO 2006/091770 (2006-08-01), None
patent: WO 2007/007119 (2007-01-01), None
patent: WO 2007/017117 (2007-02-01), None
patent: WO 2007/040940 (2007-04-01), None
patent: WO 2007/041666 (2007-04-01), None
patent: WO 2007/099561 (2007-09-01), None
patent: WO 2008/044243 (2008-04-01), None
patent: WO 2008/053334 (2008-05-01), None
patent: WO 2008/059519 (2008-05-01), None
patent: WO 2008/065410 (2008-06-01), None
patent: WO 2008/072078 (2008-06-01), None
patent: WO 2008/093205 (2008-08-01), None
patent: WO 2008/096257 (2008-08-01), None
Evans, et al., “Reduction of β-Hydroxy Ketones with Catecholborane. A Stereoselective Approach to the Synthesis of Syn 1,3-Diols”,J. Org. Chem., 1990, pp. 5190-5192, vol. 55 (18).
Greene, “Protective Groups in Organic Synthesis”, John Wiley & Sons, Inc., 1981.
Hull, et al., “Quantification Of Rosuvastatin in Human Plasma By Automated Solid-Phase Extraction Using Tandem Mass Spectrometric Detection”,Journal of Chromatography B: Biomedical Sciences&Applications, 2002, pp. 219-228, vol. 772, No. 2.
Loubinoux, et al., “The Enantioselective Synthesis of Simplified Southern-Half Fragments of Soraphen A”,Tetrahedron, 1995, pp. 3549-3558, vol. 51, No. 12.
Ohrlein, et al., “Chemo-Enzymatic Approach to Statin Side-Chain Building Blocks”,Adv. Synth. Catal., 2003, pp. 713-715, vol. 345.
Reddy, et al., “Enantioselective Synthesis of β-Hydroxy δ-Lactones: A New Approach to the Synthetic Congeners of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors”J. Org. Chem., 1991, pp. 5752-5754, vol. 56.
Shao, et al., “Asymmetric Hydrogenation of 3,5-Dioxoesters Catalyzed by Ru-binap Complex: A Short Step Asymmetric Synthesis of 6-Substituted 5,6-dihydro-2-pyrones”,Tetrahedron, 1993, pp. 1997-2010, vol. 49 (10).
Snyder, et al.,Introduction To Modem Liquid Chromatography, 2nded., John Wiley & Sons: New York, 1979, pp. 549, 552, 571-572.
Strobel, et al.,Chemical Instrumentation: A Systematic Approach, 3rded., Wiley & Sons: New York, 1989, pp. 391-393, 879, 894, 921, 922, 924-925, 953.
Szantay, et al., “Synthesis of Novel HMG-CoA Reductase Inhibitors, Naphthalene Analogs of Mevinolin”,Liebigs Ann. Chem., 1992, pp. 145-157.
Tempkin, et al., “Asymmetric Synthesis of 3,5-Dihydroxy-6(E)-heptenoate-containing HMG-CoA Reductase Inhibitors”,Tetrahedron, 1997, pp. 10659-10670, vol. 53 (31).
Watanabe, Masamichi et al., “Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors,”Bioorganic&Medicinal Chemistry, 5(2), pp. 437-444, 1997.
Witztum, “Chapter 36: Drugs Used In The Treatment Of Hyperlipoproteinemias”,Goodman&Gilman's The Pharmacological Basis Of Therapeutics, 9thed., 1996, p. 879.

Affiliated with

Also associated with

Rating

Triol form of rosuvastatin and synthesis of rosuvastatin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Triol form of rosuvastatin and synthesis of rosuvastatin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triol form of rosuvastatin and synthesis of rosuvastatin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4238368